SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 29.81-4.3%Dec 2 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who wrote (16297)10/2/2003 9:08:30 AM
From: aknahow  Read Replies (2) of 17367
 
Yes. Read the information again. Neuprex works and these pilot probe studies are going to show that it does. Then it is going to be very difficult for regulators to prevent doctors using a safe drug to save little children.

True I do wish Xoma would say more about what a pilot probe study entails.

This is the first in a series, and Baxter chewed up time, doing nothing. But again since this is the first, shareholders should be told more about what such "probes" consist of.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News